CEINGE Biotecnologie Avanzate at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
CEINGE Biotecnologie Avanzate brings 2 presentations to ESGCT 2026 in Hamburg. Its groups work on tumour immunity and inherited metabolic disease. Topics include bacterial endospores used to present tumour antigens in a melanoma model and a receptor chimera expressed in muscle that lowers atherosclerosis in mice.
| Organization | ESGCT 2026 Attendance |
|---|---|
CEINGE Biotecnologie Avanzate Naples, Italy | |
Poster Thu Oct 29 2:00pm–4:00pm Endospore-Based Antigen Presentation Enhances Tumor-Specific Immune Responses in a Murine Melanoma Model Poster Thu Oct 29 2:00pm–4:00pm High-capacity adenoviral vector-mediated expression of an LDL receptor/transferrin chimeric protein in muscle safely reduces atherosclerosis in LDLR-deficient mice |
Instantly find 20 buyers from CEINGE Biotecnologie Avanzate
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction